Free tool
FAERS Monitor: Verkazia
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 214965 or its brand name (Verkazia, Cyclosporine). Reports on generic versions are filed under their own applications.
Reports
57,120
Serious
51,865
91% of reports
Hospitalization
17,526
Death reported
10,991
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use7,916
- drug ineffective7,861
- product use in unapproved indication3,634
- pyrexia2,800
- diarrhoea2,236
- condition aggravated2,135
- nausea2,044
- pneumonia1,997
- cytomegalovirus infection1,948
- hypertension1,724
- fatigue1,721
- sepsis1,685
- rash1,627
- headache1,601
- graft versus host disease1,578
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 881 |
| 2005 | 900 |
| 2006 | 1,029 |
| 2007 | 984 |
| 2008 | 1,675 |
| 2009 | 1,917 |
| 2010 | 1,635 |
| 2011 | 2,284 |
| 2012 | 1,609 |
| 2013 | 733 |
| 2014 | 794 |
| 2015 | 763 |
| 2016 | 955 |
| 2017 | 1,234 |
| 2018 | 1,751 |
| 2019 | 2,425 |
| 2020 | 3,567 |
| 2021 | 3,629 |
| 2022 | 5,338 |
| 2023 | 5,473 |
| 2024 | 6,908 |
| 2025 | 6,091 |
| 2026 | 4,539 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,997,039 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| graft versus host diseaseSignal | 1,578 | 103.2 | 97.7 | 124,677 |
| cytomegalovirus infectionSignal | 1,948 | 48.7 | 46.5 | 80,461 |
| sepsisSignal | 1,685 | 5.6 | 5.4 | 6,352 |
| product use in unapproved indicationSignal | 3,634 | 5.5 | 5.3 | 13,212 |
| off label useSignal | 7,916 | 3.4 | 3.3 | 13,492 |
| hypertensionSignal | 1,724 | 3.0 | 2.9 | 2,322 |
| pyrexiaSignal | 2,800 | 3.0 | 2.9 | 3,753 |
| condition aggravatedSignal | 2,135 | 2.6 | 2.5 | 2,111 |
| pneumoniaSignal | 1,997 | 2.3 | 2.2 | 1,446 |
| drug ineffectiveSignal | 7,861 | 2.2 | 2.2 | 5,479 |
| rash | 1,627 | 1.4 | 1.3 | 170 |
| diarrhoea | 2,236 | 1.3 | 1.2 | 137 |
| nausea | 2,044 | 1.0 | 0.9 | 5 |
| headache | 1,601 | 0.9 | 0.9 | 6 |
| fatigue | 1,721 | 0.8 | 0.8 | 76 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.